Agios Pharmaceuticals

Agios Pharmaceutical Inc.
TypePublic
Nasdaq: AGIO
Russell 1000 Component
IndustryPharmaceuticals
Founded2008 (2008)
Headquarters,
United States
Key peopleBrian Goff (CEO)
RevenueIncrease $118 Million(2019)
Increase US$ 54.0 million (2025)
Decrease US$ 412.8 million (2025)
Total assetsDecrease US$ 1.30 billion (2025)
Total equityDecrease US$ 1.19 billion (2025)
Number of employees
536
Websiteagios.com
Footnotes
Foundation

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.